Genelux Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-25.78	-28.3	-5.21	-16.38	-13.64
Depreciation & Amortization	0.33	0.5	0.55	0.9	0.66
Share-Based Compensation	5.91	6.14	2.42	4.27	5.33
Other Operating Activities	-0.49	1.38	-1.33	4.63	0.46
Operating Cash Flow	-20.04	-20.28	-3.57	-6.59	-7.21
Capital Expenditures	-0.95	-1.03	-0.05	0	-0.02
Change in Investments	-15.36	-13.7	0	0	0
Investing Cash Flow	-16.31	-14.72	-0.05	0	-0.02
Share Issuance / Repurchase	30.29	44.11	0.12	0.29	8.99
Debt Issued / Paid	-0.23	0.22	0.97	-0.56	9.16
Other Financing Activities	-	-0.3	-1.57	-	-
Financing Cash Flow	30.07	44.02	-0.48	-0.27	18.15
Net Cash Flow	-6.28	9.02	-4.1	-6.86	10.93
Free Cash Flow	-20.99	-21.3	-3.62	-6.59	-7.23
Free Cash Flow Margin	-262312.50%	-12529.41%	-32.71%	-	-
Free Cash Flow Per Share	-0.78	-0.87	-0.40	-0.73	-0.29

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).